Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Pharmacokinetics of an intravenous bolus dose of clonidine in children undergoing surgery

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review


  1. Marked changes in platelet count and function following pediatric congenital heart surgery

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  1. Anesthesiologists’ airway management expertise: Identifying subjective and objective knowledge gaps

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  2. Evaluation of topical morphine for treatment of oral mucositis in cancer patients

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskning

  3. Anaphylaxis in children and adults

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

  4. Blood pressure in Danish children during general anaesthesia: Hypotension in a paediatric population observational (HIPPO) study

    Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

Vis graf over relationer

BACKGROUND: Clonidine is used off-label in children but only limited pediatric pharmacokinetic data are available for intravenously administered clonidine.

OBJECTIVES: To determine pharmacokinetic parameter estimates of clonidine in healthy children undergoing surgery and to investigate age-related differences. Furthermore, to investigate possible pharmacokinetic differences of clonidine between this group of children and a cohort with cardiac diseases.

METHODS: In a randomized placebo-controlled trial (The PREVENT AGITATION trial), blood samples for clonidine pharmacokinetic analysis were collected in a proportion of the enrolled patients. Healthy children with ASA score 1-2 in the age-groups 1 to <2 years and 2-5 years were randomized for blood sampling. Clonidine was administered as a single intravenous bolus of 3 µg/kg intraoperatively. Blood samples were drawn at baseline, 5, 10, 15, 30, 60 minutes after dosing and additionally every hour until discharge from the PACU. Clonidine analysis was performed on liquid chromatography-mass spectrometry.

RESULTS: Data form eighteen children were available for pharmacokinetic analysis (ASA I; male/female: 17/1; age: 1-5 years; weight 8.7-24 kg). Population parameter estimates for the 2-compartment model were similar to previous published data for children who underwent cardiac surgery. A pooled analysis including data from 59 children indicated clearance of 14.4 L h -1 70 kg -1 and volume of distribution of 192.6 L 70 kg -1 . No age-related pharmacokinetic differences and no difference in time from administration of study medication to awakening were found. Children 1 to <2 years had a shorter PACU stay than children 2-5 years (mean difference 17% 95% CI:3%-34%, P = .02).

CONCLUSION: Pharmacokinetic parameter estimates were similar for children undergoing general surgery and cardiac surgery given a single dose of intravenous clonidine. These results indicated that no dose reduction is needed in children aged 1 to <2 years compared with those 2-5 years, which was supported by pharmacodynamic observations.

TidsskriftPaediatric Anaesthesia Online
Udgave nummer5
Sider (fra-til)607-613
Antal sider7
StatusUdgivet - maj 2020

ID: 59610201